﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Mon, 20 Apr 2026 08:23:51 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/March-2022/rss/3161</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/March-2022/rss/3161" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[New and Approved]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-and-approved-47</link><description><![CDATA[  APhA Staff  

   New Formulations   

 ABROCITINIB 
(Cibinqo—Pfizer Inc.) 

  Drug class:  Janus kinase inhibitor. 

  Indication:  Cibinqo is indicated for patients who have refractory, ...]]></description><pubDate>Mon, 07 Feb 2022 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/new-and-approved-47</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3182]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[As the opioid epidemic takes a turn for the worse, do we need more potent forms of naloxone?]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/as-the-opioid-epidemic-takes-a-turn-for-the-worse-do-we-need-more-potent-forms-of-naloxone</link><description><![CDATA[  Loren Bonner  

   

 Federal agencies like FDA and CDC have cited the need for higher doses of naloxone to reverse opioid overdoses, especially as fentanyl and other synthetic opioids have ...]]></description><pubDate>Mon, 07 Feb 2022 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/as-the-opioid-epidemic-takes-a-turn-for-the-worse-do-we-need-more-potent-forms-of-naloxone</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3175]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[What are the differences among COVID-19, the flu, cold, and allergies?]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/what-are-the-differences-among-covid-19-the-flu-cold-and-allergies</link><description><![CDATA[  Clarissa Chan, PharmD  

   

 This season, pharmacists should review the differences among COVID-19, influenza, the common cold, and seasonal allergies since many of the signs and symptoms are ...]]></description><pubDate>Mon, 07 Feb 2022 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/what-are-the-differences-among-covid-19-the-flu-cold-and-allergies</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3176]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[What to watch for when patients take opioids with other medications]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/what-to-watch-for-when-patients-take-opioids-with-other-medications</link><description><![CDATA[  Clarissa Chan, PharmD  

   

 Chronic pain is common in the U.S. population and one of the main reasons patients seek medical care. Between 10% to 60% of adults 18 years and older report ...]]></description><pubDate>Mon, 07 Feb 2022 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/what-to-watch-for-when-patients-take-opioids-with-other-medications</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3177]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[FDA expands access to mifepristone to mail-order and community pharmacies]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/fda-expands-access-to-mifepristone-to-mail-order-and-community-pharmacies-1</link><description><![CDATA[  Sonya Collins  

   

 In December 2021, FDA permanently lifted a major restriction on medication abortions that had been temporarily lifted earlier in the COVID-19 pandemic. Prior to the ...]]></description><pubDate>Mon, 07 Feb 2022 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/fda-expands-access-to-mifepristone-to-mail-order-and-community-pharmacies-1</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3178]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[FDA approves new medication for asthma]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/fda-approves-new-medication-for-asthma</link><description><![CDATA[  Johanna Taylor Katroscik, PharmD  

 In December 2021, FDA approved tezepelumab-ekko (Tezspire– Amgen Inc. and AstraZeneca), a first-in-class medication indicated for patients with severe asthma. ...]]></description><pubDate>Mon, 07 Feb 2022 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/fda-approves-new-medication-for-asthma</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3179]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[What are the benefits of magnesium supplements?]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/what-are-the-benefits-of-magnesium-supplements</link><description><![CDATA[  Johanna Taylor Katroscik, PharmD  

   

 Magnesium is one of the most abundant minerals in the body and is used in numerous cellular functions. It acts as a cofactor in enzymatic reactions, is ...]]></description><pubDate>Mon, 07 Feb 2022 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/what-are-the-benefits-of-magnesium-supplements</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3180]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Scaly dermatoses: What’s that itch?]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/scaly-dermatoses-whats-that-itch</link><description><![CDATA[  Daniel L. Krinsky, BS, MS, RPh, FAPhA  

   

 Chronic scaly dermatoses include dandruff, seborrheic dermatitis, and psoriasis. These disorders involve the epidermis, the uppermost layer of ...]]></description><pubDate>Mon, 07 Feb 2022 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/scaly-dermatoses-whats-that-itch</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-3181]]></dc:identifier></item></channel></rss>